2Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[ J ]. Chest, 1992. 101 (6) : 1644-1655.
3Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS), a prospective study [ J ]. JAMA, 1995,273 (2) : 117-123.
4Hollenberg SM. Vasopressor support in septic shock [ J ]. Chest, 2007, 132(5) : 1678-1687.
5Lee SW, Hong YS, Park DW, et al. Lactic acidosis not hyperlactatemia as a predictor of in hospital mortality in septic emergency patients [ J ]. Emerg Med J, 2008,25 (10) : 659-665.
6Tisherman SA, Barie P, Bokhari F, et al. Clinical practice guideline : endpoints of resuscitation [ J ]. J Trauma, 2004,57 (4) : 898-912.
7Gando S, Kameue T, Nanzaki S, et al. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome [ J ]. Crit Care Med, 1997, 25 ( 11 ) : 1820-1826.
8Levraut J, Ciebiera JP, Chave S, et al. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction [ J ]. Am J Respir Crit Care Med, 1998, 157 (4Pt 1) : 1021-1026.
9Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock [ J ]. Crit Care Med, 2004, 32 (8) : 1637-1642.
10Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock [ J ]. N Engl J Med, 2001,345 (19) : 1368-1377.
